Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs 2021-12-09 07:35
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China 2021-12-09 06:10
China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again 2021-12-08 18:22
SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper 2021-12-08 14:00
Henlius' Phase 3 clinical study of novel PD-1 inhibitor serplulimab for the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC) meets primary study endpoint 2021-12-08 08:30
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant 2021-12-07 18:18
Overland Pharmaceuticals Partners with ArisGlobal to Accelerate Safety Capabilities 2021-12-07 17:13
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 2021-12-07 08:00
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18 2021-12-07 05:54
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations 2021-12-06 20:01
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies 2021-12-06 17:30
Odyssey Announces Agreement to Combine with BenevolentAI 2021-12-06 14:00
Brii Biosciences Included in Hong Kong Stock Connect 2021-12-06 10:54
Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration 2021-12-04 01:51
Mongolian Government To Build On COVID-19 Vaccine And Booster Success 2021-12-03 15:00
RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment 2021-12-03 13:45
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications 2021-12-03 12:37
Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy 2021-12-03 12:05
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome 2021-12-03 03:26
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis 2021-12-02 21:00
1 96 97 98 99 100 230